J Chamberlain

6.9k total citations · 1 hit paper
85 papers, 5.0k citations indexed

About

J Chamberlain is a scholar working on Oncology, Epidemiology and Genetics. According to data from OpenAlex, J Chamberlain has authored 85 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 19 papers in Epidemiology and 11 papers in Genetics. Recurrent topics in J Chamberlain's work include Colorectal Cancer Screening and Detection (30 papers), Global Cancer Incidence and Screening (28 papers) and Cervical Cancer and HPV Research (16 papers). J Chamberlain is often cited by papers focused on Colorectal Cancer Screening and Detection (30 papers), Global Cancer Incidence and Screening (28 papers) and Cervical Cancer and HPV Research (16 papers). J Chamberlain collaborates with scholars based in United Kingdom, Canada and Austria. J Chamberlain's co-authors include J D Hardcastle, T.W. Balfour, Peter James, Susan Moss, C M Mangham, Sue Moss, S S Amar, Matti Hakama, N E Day and R Ellman and has published in prestigious journals such as The Lancet, Cancer and Gut.

In The Last Decade

J Chamberlain

82 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

1996 2.1k citations J Chamberlain, C M Mangham et al. profile →

Peers

Countries citing papers authored by J Chamberlain

Since Specialization

Citations

This map shows the geographic impact of J Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Chamberlain more than expected).

Fields of papers citing papers by J Chamberlain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Chamberlain. The network helps show where J Chamberlain may publish in the future.

Co-authorship network of co-authors of J Chamberlain

This figure shows the co-authorship network connecting the top 25 collaborators of J Chamberlain. A scholar is included among the top collaborators of J Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Chamberlain. J Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer 1999 ·Gut ·M.H. Robinson, J D Hardcastle, Sue Moss, S S Amar, J Chamberlain, N C Armitage, J H Scholefield, C M Mangham	81
2	Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma 1995 ·British Journal of Dermatology ·J Melia, E. J. Cooper, Thomas Frost, R.A.C. GRAHAM-BROWN, John Hunter, (unknown), ANTHONY VIVIER, John White, Stephen Whitehead, A P Warin, (unknown), R Ellman, J Chamberlain	36
3	1995 ·Obstetrics and Gynecology ·J Chamberlain	10
4	Survival of Patients with Breast Cancer Diagnosed in the United Kingdom Trial of Early Detection of Breast Cancer 1994 ·Journal of Medical Screening ·Sue Moss, R Ellman, D Coleman, J Chamberlain, (unknown)	19
5	Meeting The health of the nation target for skin cancer: problems with tackling prevention and monitoring trends 1994 ·Journal of Public Health ·J Melia, R Ellman, J Chamberlain	12
6	The efficacy and safety of periodic mammographic breast cancer screening: Summary of report of the European Society of Mastology 1994 ·Clinical Radiology ·N J Wald, Allan Hackshaw, J Chamberlain	3
7	Investigating changes in awareness about cutaneous malignant melanoma in Britain using the Omnibus Survey 1994 ·Clinical and Experimental Dermatology ·J Melia, R Ellman, J Chamberlain	9
8	Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer 1993 ·European Journal of Cancer ·Sue Moss, D Coleman, R Ellman, J Chamberlain, A P M Forrest, A.E. Kirkpatrick, B. A. Thomas, (unknown)	22
9	Breast self-examination programmes in the trial of early detection of breast cancer: ten year findings 1993 ·British Journal of Cancer ·R Ellman, Sue Moss, D Coleman, J Chamberlain	38
10	Firmer evidence on the value of breast screening—the swedish overview 1993 ·European Journal of Cancer ·J Chamberlain	3
11	Verification of the cause of death in the trial of early detection of breast cancer 1991 ·British Journal of Cancer ·J Chamberlain, D Coleman, R Ellman, S Moss	12
12	Four and a half year follow up of women with dyskaryotic cervical smears. 1990 ·BMJ ·Astrid Fletcher, (unknown), (unknown), J Chamberlain	40
13	An insurance policy to reduce the risk of dying from breast cancer 1989 ·Clinical Radiology ·J Chamberlain	2
14	Screening and the costs of treating colorectal cancer: some preliminary results 1989 ·Public Health ·(unknown), Andrew Walker, David K. Whynes, Geoffrey W. Pye, J D Hardcastle, J Chamberlain	16
15	The organization of cervical screening in general practice. 1988 ·PubMed ·(unknown), Robert P. Edwards, Jack Cuzick, J Chamberlain	8
16	Screening for breast cancer: Workshop report 1988 ·European Journal of Cancer and Clinical Oncology ·N E Day, J Chamberlain	21
17	Reasons that some screening programmes fail to control cervical cancer. 1986 ·PubMed ·J Chamberlain	48
18	Explaining participation in programmes for the early detection of breast cancer: a comparative analysis. 1984 ·PubMed ·(unknown), J Chamberlain	5
19	Repeated screening for breast cancer. 1984 ·Journal of Epidemiology & Community Health ·J Chamberlain, R Clifford, (unknown), J. L. Price, Ian Burn	15
20	Error-rates in screening for breast cancer by clinical examination and mammography. 1979 ·PubMed ·J Chamberlain, (unknown), (unknown), (unknown), Ian Burn	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact